ITM Isotope Technologies Munich SE (ITM), a radiopharmaceutical biotech company, recently received a wholesale license issued by the New Jersey Department of Health to operate as a virtual manufacturer.
The company said that obtaining this license is an important requirement for ITM's U.S. business activities. It will allow the company to distribute its radiopharmaceutical products and make way for patient access to ITM’s radiopharmaceuticals upon their approval by the U.S. Food and Drug Administration (FDA).
ITM opened its U.S. headquarters in Princeton, NJ, in April 2023. Since then, it has been preparing for potential market registration of its targeted radiopharmaceutical pipeline product candidates.
